JP Stock MarketDetailed Quotes

Nxera Pharma (4565)

Watchlist
  • 1210
  • +33+2.80%
20min DelayTrading May 14 09:49 JST
111.00BMarket Cap-8.72P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nxera Pharma (4565) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0.00%6.64B
2.71%29.62B
44.09%6.64B
125.87%28.84B
574.06%8.11B
388.97%4.61B
-18.00%12.77B
5.25%7.29B
-46.18%3.33B
-10.09%1.2B
Cost of revenue
0.00%1.62B
7.64%8.2B
35.60%1.62B
145.52%7.62B
1,630.08%2.3B
1,194.57%1.19B
234.99%3.1B
840.86%1.75B
439.23%1.13B
-45.27%133M
Gross profit
0.00%5.03B
0.94%21.42B
47.05%5.03B
119.57%21.22B
442.80%5.81B
301.88%3.42B
-34.00%9.66B
-17.80%5.54B
-63.16%2.2B
-2.28%1.07B
Operating expense
0.00%7.22B
12.15%29.88B
11.18%7.22B
38.83%26.64B
95.05%6.39B
130.76%6.5B
71.23%19.19B
162.95%7.08B
116.26%6.03B
21.57%3.27B
Selling and administrative expenses
0.00%3.7B
-4.93%15.23B
1.40%3.7B
60.71%16.02B
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
-General and administrative expense
0.00%3.7B
-4.93%15.23B
1.40%3.7B
60.71%16.02B
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
Research and development costs
0.00%3.81B
22.43%14.47B
20.39%3.81B
17.28%11.82B
11.62%2.32B
61.62%3.16B
35.16%10.08B
67.23%3.06B
54.49%2.97B
9.93%2.08B
Other operating expenses
0.00%8M
1,745.00%1.85B
300.00%8M
6.38%100M
-96.67%1M
--2M
4,600.00%94M
6,000.00%61M
--2M
500.00%30M
Total other operating income
0.00%295M
28.47%1.66B
-7.52%295M
36.55%1.29B
3.67%311M
27.09%319M
50.80%944M
--0
790.91%392M
156.41%300M
Operating profit
0.00%-2.19B
-56.04%-8.46B
28.71%-2.19B
43.07%-5.42B
73.77%-578M
-56.62%-3.08B
-377.24%-9.53B
-137.87%-1.53B
-219.91%-3.82B
-37.92%-2.2B
Net non-operating interest income (expenses)
0.00%37M
-952.56%-6.49B
-86.79%37M
165.94%761M
-29.64%216M
177.23%280M
-1,140.86%-1.15B
-531.03%-1.28B
-330.33%-281M
420.34%307M
Non-operating interest income
0.00%286M
-36.08%987M
-38.49%286M
15.14%1.54B
-17.50%415M
70.33%465M
102.26%1.34B
1,146.43%349M
25.86%365M
117.75%503M
Non-operating interest expense
0.00%249M
854.66%7.48B
34.59%249M
-68.62%783M
1.53%199M
7.56%185M
230.03%2.5B
605.63%1.63B
284.52%646M
13.95%196M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
Special income (charges)
Other non-operating income (expenses)
Income before tax
0.00%-2.16B
-220.68%-14.95B
22.89%-2.16B
56.35%-4.66B
80.92%-362M
-50.08%-2.8B
-1,090.72%-10.68B
-167.25%-2.82B
-449.66%-4.11B
-6.27%-1.9B
Income tax
0.00%-1.4B
-1,475.00%-2.42B
-387.84%-1.4B
105.05%176M
185.55%1.06B
205.21%485M
-601.01%-3.49B
-550.26%-2.61B
-4.76%820M
-290.85%-1.24B
Net income
0.00%-760M
-158.99%-12.53B
76.84%-760M
32.74%-4.84B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
Net income continuous operations
0.00%-760M
-158.99%-12.53B
76.84%-760M
32.74%-4.84B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
Noncontrolling interests
Net income attributable to the company
0.00%-760M
-158.99%-12.53B
76.84%-760M
32.74%-4.84B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
0.00%-760M
-158.99%-12.53B
76.84%-760M
32.74%-4.84B
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
Gross dividend payment
Basic earnings per share
0.00%-8.45
-157.42%-138.8
76.96%-8.45
38.15%-53.92
-97.51%-15.86
-114.38%-36.68
-1,962.82%-87.18
-104.83%-2.13
-1,665.71%-59.81
55.29%-8.03
Diluted earnings per share
0.00%-8.45
-157.42%-138.8
76.96%-8.45
38.15%-53.92
-97.51%-15.86
-114.38%-36.68
-1,982.94%-87.18
-104.83%-2.13
-1,682.28%-59.81
55.29%-8.03
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0.00%6.64B2.71%29.62B44.09%6.64B125.87%28.84B574.06%8.11B388.97%4.61B-18.00%12.77B5.25%7.29B-46.18%3.33B-10.09%1.2B
Cost of revenue 0.00%1.62B7.64%8.2B35.60%1.62B145.52%7.62B1,630.08%2.3B1,194.57%1.19B234.99%3.1B840.86%1.75B439.23%1.13B-45.27%133M
Gross profit 0.00%5.03B0.94%21.42B47.05%5.03B119.57%21.22B442.80%5.81B301.88%3.42B-34.00%9.66B-17.80%5.54B-63.16%2.2B-2.28%1.07B
Operating expense 0.00%7.22B12.15%29.88B11.18%7.22B38.83%26.64B95.05%6.39B130.76%6.5B71.23%19.19B162.95%7.08B116.26%6.03B21.57%3.27B
Selling and administrative expenses 0.00%3.7B-4.93%15.23B1.40%3.7B60.71%16.02B199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B
-General and administrative expense 0.00%3.7B-4.93%15.23B1.40%3.7B60.71%16.02B199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B
Research and development costs 0.00%3.81B22.43%14.47B20.39%3.81B17.28%11.82B11.62%2.32B61.62%3.16B35.16%10.08B67.23%3.06B54.49%2.97B9.93%2.08B
Other operating expenses 0.00%8M1,745.00%1.85B300.00%8M6.38%100M-96.67%1M--2M4,600.00%94M6,000.00%61M--2M500.00%30M
Total other operating income 0.00%295M28.47%1.66B-7.52%295M36.55%1.29B3.67%311M27.09%319M50.80%944M--0790.91%392M156.41%300M
Operating profit 0.00%-2.19B-56.04%-8.46B28.71%-2.19B43.07%-5.42B73.77%-578M-56.62%-3.08B-377.24%-9.53B-137.87%-1.53B-219.91%-3.82B-37.92%-2.2B
Net non-operating interest income (expenses) 0.00%37M-952.56%-6.49B-86.79%37M165.94%761M-29.64%216M177.23%280M-1,140.86%-1.15B-531.03%-1.28B-330.33%-281M420.34%307M
Non-operating interest income 0.00%286M-36.08%987M-38.49%286M15.14%1.54B-17.50%415M70.33%465M102.26%1.34B1,146.43%349M25.86%365M117.75%503M
Non-operating interest expense 0.00%249M854.66%7.48B34.59%249M-68.62%783M1.53%199M7.56%185M230.03%2.5B605.63%1.63B284.52%646M13.95%196M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 0
Special income (charges)
Other non-operating income (expenses)
Income before tax 0.00%-2.16B-220.68%-14.95B22.89%-2.16B56.35%-4.66B80.92%-362M-50.08%-2.8B-1,090.72%-10.68B-167.25%-2.82B-449.66%-4.11B-6.27%-1.9B
Income tax 0.00%-1.4B-1,475.00%-2.42B-387.84%-1.4B105.05%176M185.55%1.06B205.21%485M-601.01%-3.49B-550.26%-2.61B-4.76%820M-290.85%-1.24B
Net income 0.00%-760M-158.99%-12.53B76.84%-760M32.74%-4.84B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M
Net income continuous operations 0.00%-760M-158.99%-12.53B76.84%-760M32.74%-4.84B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M
Noncontrolling interests
Net income attributable to the company 0.00%-760M-158.99%-12.53B76.84%-760M32.74%-4.84B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 0.00%-760M-158.99%-12.53B76.84%-760M32.74%-4.84B-116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M
Gross dividend payment
Basic earnings per share 0.00%-8.45-157.42%-138.876.96%-8.4538.15%-53.92-97.51%-15.86-114.38%-36.68-1,962.82%-87.18-104.83%-2.13-1,665.71%-59.8155.29%-8.03
Diluted earnings per share 0.00%-8.45-157.42%-138.876.96%-8.4538.15%-53.92-97.51%-15.86-114.38%-36.68-1,982.94%-87.18-104.83%-2.13-1,682.28%-59.8155.29%-8.03
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +4.07%
Sample Name
Sample Code
 +1.55%
Sample Name
Sample Code
 +1.37%
4
SINOPEC CORP
00386
+0.65%
5
CNOOC
00883
+0.08%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +67.26%
Sample Name
Sample Code
 +44.28%
Sample Name
Sample Code
 +32.47%
4
Loongson Technology Corporation
688047
+31.76%
5
Business-intelligence Of Oriental Nations Corporation
300166
+27.06%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -